Pulse Therapeutics closes in on a $1.5 million fundraising goal, having so far raised a little over $1 million.
Pulse Therapeutics is nearing its $1.5 million goal in an active fundraising effort that has so far brought in just over $1 million, according to a SEC filing.
St. Louis-based Pulse Therapeutics is developing stroke treatment technologies based on tiny, biologically safe iron particles that could deliver drug therapy.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1mtGGcf
Cap comentari:
Publica un comentari a l'entrada